Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded ...

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...